Cargando…

Impact of Hormone Replacement Therapy on the Overall Survival and Progression Free Survival of Ovarian Cancer Patients: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: The standard treatment course for ovarian cancer virtually always induces menopause with subsequent symptoms. This systematic review and meta-analysis strived to further elucidate the safety of Hormone Replacement Therapy in the setting of ovarian cancer treatments by investigating i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Achimaș-Cadariu, Patriciu Andrei, Păun, Diana Loreta, Pașca, Andrei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856775/ https://www.ncbi.nlm.nih.gov/pubmed/36672307 http://dx.doi.org/10.3390/cancers15020356

Ejemplares similares

CT-guided procedures: an initial experience
por: ROMAN, ANDREI, et al.
Publicado: (2018)

The role of medical registries, potential applications and limitations
por: Pop, Bogdan, et al.
Publicado: (2019)

Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival
por: Gracia, Myriam, et al.
Publicado: (2023)

A Comparative Study between 18F-FDG PET/CT and Conventional Imaging in the Evaluation of Progressive Disease and Recurrence in Ovarian Carcinoma
por: Rusu, George, et al.
Publicado: (2021)

Unusual skin metastasis in a patient with recurrent micropapillary serous ovarian carcinoma – a case report and review of the literature
por: ACHIMAŞ-CADARIU, PATRICIU, et al.
Publicado: (2015)

Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present
por: Achimas-Cadariu, Patriciu, et al.
Publicado: (2022)

Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis
por: Sjoquist, Katrin M., et al.
Publicado: (2018)

Fertility preservation in Hodgkin’s lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era
por: Traila, Alexandra, et al.
Publicado: (2018)

Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
por: Li, Jiayi, et al.
Publicado: (2022)

The development of scientific reasoning in medical education: a psychological perspective
por: BARZ, DANIELA LUMINITA, et al.
Publicado: (2016)

Recurrence-free survival as a putative surrogate for overall survival in phase III trials of curative-intent treatment of colorectal liver metastases: Systematic review
por: Araujo, Raphael L C, et al.
Publicado: (2017)

The Importance of Ubiquitin E3 Ligases, SCF and APC/C, in Human Cancers
por: BOCHIS, OVIDIU VASILE, et al.
Publicado: (2015)

Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma
por: Han, Kelong, et al.
Publicado: (2015)

Systematic Review and Meta-Analysis of Correlation of Progression-Free Survival-2 and Overall Survival in Solid Tumors
por: Chowdhury, Simon, et al.
Publicado: (2020)

Comprehensive Analysis of the Expression of Key Genes Related to Hippo Signaling and Their Prognosis Impact in Ovarian Cancer
por: Kubelac, Paul, et al.
Publicado: (2021)

Progression-free or overall survival…revisited in BOLERO-2
por: Gupta, Sudeep
Publicado: (2014)

Antiproliferative Ruthenium Complexes Containing Curcuminoid Ligands Tested In Vitro on Human Ovarian Tumor Cell Line A2780, towards Their Capability to Modulate the NF-κBTranscription Factor, FGF-2 Growth Factor, and MMP-9 Pathway
por: Leskovská, Janka, et al.
Publicado: (2022)

Surrogate threshold effect based on a meta-analysis for the predictive value of progression-free survival for overall survival in hormone receptor-positive, HER2-negative metastatic breast cancer
por: Lux, Michael Patrick, et al.
Publicado: (2019)

Prognostic factors for in-transit metastasis in patients with malignant melanoma
por: Gâta, Vlad Alexandru, et al.
Publicado: (2022)

Predictors of limph node metastasis in endometrial cancer
por: IGNAT, FLORIN LAURENTIU, et al.
Publicado: (2013)

Postoperative Hormone Replacement Therapy and Survival in Women with Ovarian Cancer
por: Ji, Eunjeong, et al.
Publicado: (2022)

Clinical Approach to the Patient in Critical State Following Immunotherapy and/or Stem Cell Transplantation: Guideline for the On-Call Physician
por: Constantinescu, Catalin, et al.
Publicado: (2019)

Cancer-Associated Stemness and Epithelial-to-Mesenchymal Transition Signatures Related to Breast Invasive Carcinoma Prognostic
por: Groza, Iulia-Monica, et al.
Publicado: (2020)

Prognostic factors for progression‐free and overall survival in malignant pleural mesothelioma
por: Guzmán‐Casta, Jordi, et al.
Publicado: (2021)

miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples
por: Braicu, Ovidiu-Leonard, et al.
Publicado: (2017)

Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis
por: Paoletti, Xavier, et al.
Publicado: (2020)

Overall survival and progression-free survival with endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: review
por: Reinert, Tomás, et al.
Publicado: (2017)

Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
por: Beauchemin, Catherine, et al.
Publicado: (2014)

Prognostic Factors of Atypical Meningioma: Overall Survival Rate and Progression Free Survival Rate
por: Lee, Jae Ho, et al.
Publicado: (2017)

Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival
por: Jatoi, Aminah, et al.
Publicado: (2015)

p53 siRNA - a therapeutic tool with significant implication in the modulation of apoptosis and angiogenic pathways
por: BRAICU, OVIDIU, et al.
Publicado: (2015)

Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study
por: Heemskerk-Gerritsen, Bernadette A. M., et al.
Publicado: (2022)

Correlation between progression-free survival and overall survival in patients with ovarian cancer after cytoreductive surgery: a systematic literature review
por: Chase, Dana M, et al.
Publicado: (2023)

Novel Phenothiazine-Bridged Porphyrin-(Hetero)aryl dyads: Synthesis, Optical Properties, In Vitro Cytotoxicity and Staining of Human Ovarian Tumor Cell Lines
por: Molnar, Eva, et al.
Publicado: (2020)

Fertility sparing surgery vs radical surgery for epithelial ovarian cancer: a meta-analysis of overall survival and disease-free survival
por: Liu, Denghua, et al.
Publicado: (2020)

Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
por: Cicero, Giuseppe, et al.
Publicado: (2018)

Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer
por: Storr, Sarah J, et al.
Publicado: (2012)

SERS-based differential diagnosis between multiple solid malignancies: breast, colorectal, lung, ovarian and oral cancer
por: Moisoiu, Vlad, et al.
Publicado: (2019)

Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer
por: Paik, E Sun, et al.
Publicado: (2017)

Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma
por: Amdahl, Jordan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rsrbobk6r6apf25itqr16j7l8v